Fynefta TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: fingolimod
Brand name
(ARTG)
: FYNEFTA fingolimod (as hydrochloride) 0.25 mg capsule blister packWhat this medicine is used for
(ARTG)
FYNEFTA is indicated for the treatment of adult and paediatric patients of 10 years of age and above with relapsing forms of multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, hard
- Oral
- Ivory opaque (body and cap), size 3, with black radial imprint FTY 0.25 mg on cap and black radial band on body containing white to almost white powder
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 28 pack
- 7 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient fingolimod
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
